Original ArticleRetinal Endovascular Lysis in Ischemic Central Retinal Vein Occlusion: One-Year Results of a Pilot Study
Section snippets
Patients and Methods
Between 2003 and 2005, patients with CRVO were screened for eligibility (see below) and consecutively included in the study.
Results
From August 2002 to March 2005, we prospectively enrolled 13 patients in the study. So far, all patients have completed the 1-year control. Patient characteristics are depicted in detail in Table 1.
Discussion
In the management of acute major vessel occlusion, the use of fibrinolytic agents such as recombinant tissue plasminogen activator is widely accepted. Today, the spectrum of indications for thrombolytic drugs comprises acute myocardial infarction, lung embolism, ischemic stroke, deep vein thrombosis, and acute arterial occlusions of the lower limbs. Based on the histopathological and clinical features of retinal vessel occlusion, fibrinolysis aiming at early restoration of blood flow appears to
References (32)
Prevalent misconceptions about acute retinal vascular occlusive disorders
Prog Retin Eye Res
(2005)Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein
Am J Ophthalmol
(1998)- et al.
Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion
Ophthalmology
(2001) - et al.
Retinal ischemia and risk of neovascularization following central retinal vein obstruction
Ophthalmology
(1982) - et al.
Relative afferent pupillary defect in central retinal vein occlusion
Ophthalmology
(1986) - et al.
Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults
Am J Ophthalmol
(2003) - et al.
The natural course of central retinal vein occlusion
Am J Ophthalmol
(1990) - et al.
Effects of cytokines on vascular endothelium: their role in vascular and immune injury
Kidney Int
(1989) Retinal vein occlusion
Indian J Ophthalmol
(1994)Central retinal vein occlusion: what’s the story?
Br J Ophthalmol
(1997)
A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation
Br J Ophthalmol
Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and non-ischaemic central retinal vein occlusion
Ophthalmologica
Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study
Graefes Arch Clin Exp Ophthalmol
Management of central retinal vein occlusion
Ophthalmologica
Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases
Retina
Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion
Ophthalmologica
Cited by (0)
Manuscript no. 2006-500.